| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 66 | +48.48% | +3.88% | +0.28% | +3.59% | -0.15% | 1.59 |
| 14d | 66 | +33.33% | +6.87% | +0.58% | +6.29% | -1.83% | 1.51 |
| 30d | 66 | +27.27% | -1.46% | +0.25% | -1.70% | -8.51% | -0.43 |
| 60d | 66 | +34.85% | +7.16% | -0.19% | +7.35% | -13.11% | 1.20 |
| 90d | 66 | +34.85% | +0.91% | -0.30% | +1.21% | -14.06% | 0.20 |
| 180d | 66 | +45.45% | +12.76% | +3.23% | +9.53% | +0.91% | 1.08 |
| 1y | 66(4 pending) | +20.97% | -4.27% | +7.46% | -11.74% | -16.79% | -1.21 |
| 2y | 66(14 pending) | +13.46% | -33.22% | +28.98% | -62.20% | -67.63% | -8.19 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CLYM CLIMB BIO, INC. | PURCHASEGRANT Stock grant | 70,284 | — | — | 70,284 | Jun 29, 2026 | Jul 1, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jun 24, 2026 | Jun 26, 2026 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASEGRANT Stock grant | 34,000 | — | — | 34,000 | Jun 18, 2026 | Jun 22, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,275 | — | — | 20,275 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,100 | — | — | 22,100 | Jun 15, 2026 | Jun 15, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,500 | — | — | 15,500 | Jun 11, 2026 | Jun 12, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,500 | — | — | 11,750 | Jun 11, 2026 | Jun 12, 2026 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 5, 2026 | Jun 8, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 53,250 | — | — | 53,250 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 35,500 | — | — | 48,300 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,366 | — | — | 9,366 | May 18, 2026 | May 20, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 53,407 | $24.83 | $1.33M | 6,314,525 | May 6, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 14,611 | $23.77 | $347.3K | 6,261,118 | May 6, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 10,268 | $25.00 | $256.7K | 6,246,507 | May 5, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 87,143 | $24.59 | $2.14M | 6,236,239 | May 5, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 2,541,250 | $18.00 | $45.74M | 6,149,096 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 27,720 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 64,680 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 42,341 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 56,972 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 18,146 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | SALE | 10,054 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 3,607,846 | — | — | 3,607,846 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 133,750 | $18.00 | $2.41M | 354,938 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 221,188 | — | — | 221,188 | May 4, 2026 | May 6, 2026 ↗ | View → |
| COAG HEMAB THERAPEUTICS HOLDINGS, INC. | PURCHASE | 1,009,052 | — | — | 1,009,052 | May 4, 2026 | May 6, 2026 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASEGRANT Stock grant | 2,106,000 | $9.50 | $20.01M | 22,546,000 | Apr 29, 2026 | Apr 29, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,888,888 | $1.80 | $7.00M | 11,803,094 | Apr 22, 2026 | Apr 23, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,060,606 | $3.30 | $20.00M | 19,103,785 | Mar 16, 2026 | Mar 18, 2026 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASE | 7,111 | $3.50 | $24.9K | 3,403,429 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASE | 101,462 | $2.86 | $290.2K | 3,396,318 | Dec 12, 2025 | Dec 15, 2025 ↗ | View → |
| CLYM CLIMB BIO, INC. | SALE | 20,440,000 | — | — | 3,081,757 | Dec 11, 2025 | Dec 15, 2025 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASEGRANT Stock grant | 20,440,000 | — | — | 20,440,000 | Dec 11, 2025 | Dec 15, 2025 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASE | 213,099 | $2.18 | $464.6K | 3,294,856 | Dec 11, 2025 | Dec 15, 2025 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 9,375,000 | $3.20 | $30.00M | 18,554,273 | Sep 26, 2025 | Sep 30, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jun 25, 2025 | Jun 27, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,275 | — | — | 20,275 | Jun 13, 2025 | Jun 17, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,500 | — | — | 13,500 | Jun 11, 2025 | Jun 11, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,750 | — | — | 6,250 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,667 | — | — | 11,667 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,800 | — | — | 12,800 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 19,500 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| CLYM CLIMB BIO, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASEGRANT Stock grant | 16,000 | — | — | 16,000 | Jun 4, 2025 | Jun 6, 2025 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 162,539 | $0.98 | $159.3K | 6,237,482 | May 14, 2025 | May 14, 2025 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 52,974 | $0.98 | $51.9K | 6,074,943 | May 13, 2025 | May 14, 2025 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 320,913 | $0.86 | $276.0K | 6,021,969 | May 12, 2025 | May 14, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 110,206 | $31.02 | $3.42M | 10,141,287 | Mar 7, 2025 | Mar 7, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 372,093 | $30.78 | $11.45M | 10,031,081 | Mar 6, 2025 | Mar 7, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 304,287 | $30.56 | $9.30M | 9,621,533 | Mar 5, 2025 | Mar 7, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 37,455 | $31.30 | $1.17M | 9,658,988 | Mar 5, 2025 | Mar 7, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 1,200,000 | $44.75 | $53.70M | 9,317,246 | Oct 18, 2024 | Oct 22, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE | 3,410,335 | $1.08 | $3.68M | 1,725,348 | Aug 9, 2024 | Aug 13, 2024 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE | 114,759 | $1.08 | $123.9K | 300,853 | Aug 9, 2024 | Aug 13, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,500 | — | — | 2,500 | Jun 26, 2024 | Jun 28, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,350 | — | — | 8,350 | Jun 26, 2024 | Jun 28, 2024 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASEGRANT Stock grant | 13,000 | — | — | 13,000 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 20, 2024 | Jun 24, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,275 | — | — | 20,275 | Jun 20, 2024 | Jun 24, 2024 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | May 24, 2024 | May 24, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,530,000 | $8.50 | $30.00M | 7,914,206 | Apr 11, 2024 | Apr 15, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 280,219 | — | — | 280,219 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 13,964,285 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 296,875 | $16.00 | $4.75M | 1,884,787 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 17,000,000 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 1,587,912 | — | — | 1,587,912 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 15,625 | $16.00 | $250.0K | 295,844 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 3,000,000 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 2,464,286 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 505,954 | $9.79 | $4.95M | 9,958,073 | Mar 27, 2024 | Mar 27, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 457,745 | $9.55 | $4.37M | 9,452,119 | Mar 26, 2024 | Mar 27, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 437,600 | $9.06 | $3.96M | 8,994,374 | Mar 25, 2024 | Mar 27, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE | 64,971 | $15.03 | $976.5K | 694,755 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 164,729 | — | — | 164,729 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 694,755 | — | — | 694,755 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,580 | — | — | 10,580 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,371 | — | — | 5,371 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,000 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 54,582 | — | — | 54,582 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,386,301 | — | — | 2,386,301 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE | 933,038 | $15.03 | $14.02M | 3,319,339 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 1,397,849 | $46.50 | $65.00M | 1,397,849 | Mar 4, 2024 | Mar 6, 2024 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 2,557,593 | $10.64 | $27.21M | 9,179,273 | Feb 9, 2024 | Feb 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 191,309 | $3.83 | $732.7K | 8,556,774 | Sep 21, 2023 | Sep 25, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 2,508,691 | $2.97 | $7.45M | 8,365,465 | Sep 21, 2023 | Sep 25, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE | 3,750,000 | $6.20 | $23.25M | 5,856,774 | Aug 29, 2023 | Aug 31, 2023 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 1,777,778 | $9.00 | $16.00M | 5,135,683 | Aug 18, 2023 | Aug 22, 2023 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 5,161,290 | $7.75 | $40.00M | 13,043,179 | Jul 21, 2023 | Jul 25, 2023 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 495,008 | $12.46 | $6.17M | 8,117,246 | Jul 19, 2023 | Jul 21, 2023 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASE | 503,226 | $12.46 | $6.27M | 503,226 | Jul 19, 2023 | Jul 21, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 27, 2023 | Jun 28, 2023 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | SALEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 6, 2023 | Jun 13, 2023 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE | 1,051,263 | — | — | 0 | Nov 17, 2022 | Nov 21, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE | 994,706 | — | — | 994,706 | Nov 17, 2022 | Nov 21, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE | 3,389,500 | $12.50 | $42.37M | 4,384,206 | Nov 17, 2022 | Nov 21, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE | 2,452,947 | — | — | 0 | Nov 17, 2022 | Nov 21, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE | 426,302 | — | — | 426,302 | Nov 17, 2022 | Nov 21, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,235 | — | — | 35,235 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 2,106,774 | — | — | 2,106,774 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 902,904 | — | — | 902,904 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 100 | $7.99 | $799 | 3,773,517 | Aug 4, 2022 | Aug 5, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 1,809 | $7.48 | $13.5K | 3,773,417 | Aug 3, 2022 | Aug 5, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 8,281 | $7.91 | $65.5K | 3,771,608 | Jul 27, 2022 | Jul 28, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 14,938 | $7.71 | $115.2K | 3,763,327 | Jul 26, 2022 | Jul 28, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 302 | $7.99 | $2.4K | 3,748,389 | Jun 21, 2022 | Jun 23, 2022 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 15, 2022 | Jun 21, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 61,424 | $7.97 | $489.4K | 3,748,087 | Jun 14, 2022 | Jun 15, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 20,000 | $7.90 | $158.0K | 3,686,663 | Jun 13, 2022 | Jun 15, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 425,497 | — | — | 0 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 1,052,851 | — | — | 1,052,851 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 3,642,229 | — | — | 3,642,229 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 1,508,048 | — | — | 0 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 646,306 | — | — | 0 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 2,979,451 | $12.00 | $35.75M | 6,621,680 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 2,199,741 | — | — | 0 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 249,749 | $12.00 | $3.00M | 1,302,600 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 207,672 | — | — | 207,672 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 211,410 | — | — | 0 | May 10, 2022 | May 12, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASEGRANT Stock grant | 11,667 | — | — | 11,667 | May 6, 2022 | May 10, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 1,551,053 | $15.00 | $23.27M | 3,251,051 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 115,613 | $15.00 | $1.73M | 415,612 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE | 1,699,998 | — | — | 0 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 299,999 | — | — | 299,999 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE | 299,999 | — | — | 0 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASE | 1,699,998 | — | — | 1,699,998 | Mar 29, 2022 | Mar 31, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 241,727 | $12.27 | $2.96M | 13,381,054 | Mar 15, 2022 | Mar 16, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 342,143 | $12.35 | $4.22M | 13,139,327 | Mar 14, 2022 | Mar 16, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 337,492 | $12.77 | $4.31M | 12,797,184 | Mar 11, 2022 | Mar 11, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 256,992 | $12.95 | $3.33M | 12,459,692 | Mar 10, 2022 | Mar 11, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 40,154 | $12.99 | $521.8K | 12,202,700 | Mar 9, 2022 | Mar 11, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 245,701 | $12.86 | $3.16M | 12,162,546 | Mar 8, 2022 | Mar 8, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 337,901 | $12.61 | $4.26M | 11,916,845 | Mar 7, 2022 | Mar 8, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 63,662 | $12.99 | $827.2K | 11,578,944 | Mar 4, 2022 | Mar 8, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 138,255 | $12.89 | $1.78M | 11,515,282 | Mar 2, 2022 | Mar 2, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 294,864 | $12.98 | $3.83M | 11,377,027 | Mar 1, 2022 | Mar 2, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 8,746 | $12.97 | $113.4K | 11,082,163 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 18,991 | $12.99 | $246.7K | 11,073,417 | Feb 25, 2022 | Feb 25, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 186,467 | $13.03 | $2.43M | 11,054,426 | Feb 24, 2022 | Feb 25, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 214,922 | $13.41 | $2.88M | 10,867,959 | Feb 23, 2022 | Feb 25, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 214,922 | $13.46 | $2.89M | 10,653,037 | Feb 22, 2022 | Feb 22, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 166,229 | $14.12 | $2.35M | 10,438,115 | Feb 18, 2022 | Feb 22, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 166,229 | $14.78 | $2.46M | 10,271,886 | Feb 17, 2022 | Feb 22, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 166,200 | $14.98 | $2.49M | 10,105,657 | Feb 16, 2022 | Feb 16, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 166,200 | $14.99 | $2.49M | 9,939,457 | Feb 15, 2022 | Feb 16, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 166,229 | $14.72 | $2.45M | 9,773,257 | Feb 14, 2022 | Feb 16, 2022 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 507,724 | — | — | 507,724 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 187,214 | $17.00 | $3.18M | 1,185,767 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | SALE | 507,724 | — | — | 0 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | SALE | 998,553 | — | — | 0 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 2,762,786 | $17.00 | $46.97M | 7,913,537 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | SALE | 5,150,751 | — | — | 0 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 5,150,751 | — | — | 5,150,751 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| CTKB CYTEK BIOSCIENCES, INC. | PURCHASE | 998,553 | — | — | 998,553 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 1,184,366 | — | — | 1,184,336 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | SALE | 1,184,366 | — | — | 0 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 115,668 | $16.00 | $1.85M | 1,300,034 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 1,759,332 | $16.00 | $28.15M | 7,881,889 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 6,122,557 | — | — | 6,122,557 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | SALE | 6,122,557 | — | — | 0 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 588,850 | — | — | 588,850 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | SALE | 588,850 | — | — | 0 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |